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Introduction: Tendinopathies, especially jumper’s knee, often remain rebel to conservative treatments. 
Several experimental studies have shown the healing properties of platelet and their growth factors. 
Researches have specifically demonstrated the platelets action as mediator and/or enhancer of tissue 
healing. The aim of our study was to investigate the effect of 1 injection of PRP in patients suffering from 
chronic jumper’s knee. Our protocol was approved by Ethic Committee of University and University 
Hospital of Liège.
Results: At this time, 10 patients with jumper’s knee were included in our study. Pre-injection tests 
revealed pain of the upper part of the patellar tendon just below the patella, associated with loss of 
function. Imaging exams confirmed diagnosis. Six weeks post-injection, the clinical status was 
improved in all patients, with a significant decrease of algo-functional scores. The pain reported during 
functional assessments was decreased (in particular for the eccentric actions), yet no significant 
improvement of physical performances was observed. We found no significant differences between 
imaging exams before and 6 weeks after PRP injection.
Conclusion: One in situ 
injection of PRP clinically 
improved patients with jumper’s 
knee 6 weeks after treatment. 
All the 10 patients reported a 
decrease of pain during day-life 
and through physical activities. 
However nor functional 
performances neither imaging 
were improved. 
Methods: Patients performed imaging (US and MRI) and functional assessments, and a clinical 
examination using an algometer, before treatment and 6 weeks after PRP treatment. They were also 
invited to answer to questionnaire relative to pain and functional status. PRP was obtained from 
autologous blood using an apheresis system (COM.TEC, Fresenius). The injection of 6mL of PRP was 
realised without local anaesthesia into the proximal insertion of the patellar tendon. A 48h rest-time was 
recommended after infiltration. Afterwards, a submaximal eccentric reeducation was initiated 1 week 
after infiltration 3 times a week during 5 weeks. In case of pain, anti-inflammatory drugs were prohibited 
and patient were encouraged to take class I or II painbrakers. 
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